4.6 Article

Environmentally Resilient Microfluidic Point-of-Care Immunoassay Enables Rapid Diagnosis of Talaromycosis

Related references

Note: Only part of the references are listed.
Article Immunology

Superiority of a Novel Mp1p Antigen Detection Enzyme Immunoassay Compared to Standard BACTEC Blood Culture in the Diagnosis of Talaromycosis

Nguyen T. M. Thu et al.

Summary: The study assessed the accuracy of Mp1p antigen-detecting enzyme immunoassay in diagnosing talaromycosis, showing high specificity and sensitivity compared to blood culture. Additionally, paired plasma and urine testing significantly increased sensitivity, providing a new tool for rapid diagnosis and potentially reducing mortality rates.

CLINICAL INFECTIOUS DISEASES (2021)

Article Microbiology

Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts

Nira R. Pollock et al.

Summary: The study evaluated the performance of the Abbott BinaxNOW COVID-19 Ag card in a community testing site and found high sensitivity in newly symptomatic adults, but lower sensitivity in children and asymptomatic individuals, revealing potential limitations of the BinaxNOW test.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

Rapid test to assess the escape of SARS-CoV-2 variants of concern

Jacob T. Heggestad et al.

Summary: CoVariant-SCAN is a rapid test developed to detect neutralizing antibodies against different SARS-CoV-2 variants, showing consistent results with live virus neutralization assays and aiding in the rapid assessment of antibody response.

SCIENCE ADVANCES (2021)

Article Cell Biology

Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR

Cassio M. Fontes et al.

Summary: This study presents a new ultrasensitive point-of-care immunoassay, the EBOV D4 assay, which can be used for early detection, containment, and treatment of Ebola virus outbreaks in low-resource settings.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Infectious Diseases

An inexpensive point-of-care immunochromatographic test for Talaromyces marneffei infection based on the yeast phase specific monoclonal antibody 4D1 and Galanthus nivalis agglutinin

Kritsada Pruksaphon et al.

Summary: A novel immunochromatographic strip test (ICT) was developed for the detection of T. marneffei antigens in clinical urine specimens, showing high sensitivity (89.47%) and specificity (100%) based on validation with 341 urine samples. The ICT provides a rapid and highly accurate diagnostic tool for T. marneffei infection, suitable for clinical application in endemic areas.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Article Multidisciplinary Sciences

Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test

Jacob T. Heggestad et al.

Summary: The microfluidic point-of-care test can profile antibody responses against multiple SARS-CoV-2 antigens and detect the prognostic biomarker IP-10, making it essential for COVID-19 management. Its high sensitivity, specificity, and diagnostic and tracking capabilities for severe patients, along with the ability to be globally deployed, make it a valuable tool in combating COVID-19.

SCIENCE ADVANCES (2021)

Article Oncology

Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates

Daniel Y. Joh et al.

Summary: The EpiView-D4 is a multimodal cellphone-based platform that can evaluate cellular morphology and molecular expression of clinically relevant biomarkers in breast tissue specimens within 1 hour, offering a promising alternative to invasive pathology services in limited-resource settings for effective breast cancer management.

NPJ BREAST CANCER (2021)

Article Medicine, General & Internal

COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

Tim Peto

Summary: The study found that four LFDs have desirable performance characteristics in viral antigen detection, with Innova LFD showing good sensitivity and specificity. The potential issues of kit failure rates and training impact were noted. LFDs can be used for mass population testing to identify infectious individuals.

ECLINICALMEDICINE (2021)

Article Biotechnology & Applied Microbiology

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Jeffrey D. Whitman et al.

NATURE BIOTECHNOLOGY (2020)

Article Immunology

Occult Talaromyces marneffei Infection Unveiled by the Novel Mp1p Antigen Detection Assay

Vo Trieu Ly et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

Review Biochemical Research Methods

Capillary microfluidics in microchannels: from microfluidic networks to capillaric circuits

Ayokunle Olanrewaju et al.

LAB ON A CHIP (2018)

Article Medicine, General & Internal

A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis

Thuy Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Multidisciplinary Sciences

Inkjet-printed point-of-care immunoassay on a nanoscale polymer brush enables subpicomolar detection of analytes in blood

Daniel Y. Joh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)